학술논문
HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor–Mutated Non–Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based...
Document Type
Article
Author
Yu, Helena A.; Goto, Yasushi; Hayashi, Hidetoshi; Felip, Enriqueta; Chih-Hsin Yang, James; Reck, Martin; Yoh, Kiyotaka; Lee, Se-Hoon; Paz-Ares, Luis; Besse, Benjamin; Bironzo, Paolo; Kim, Dong-Wan; Johnson, Melissa L.; Wu, Yi-Long; John, Thomas; Kao, Steven; Kozuki, Toshiyuki; Massarelli, Erminia; Patel, Jyoti; Smit, Egbert
Source
Journal of Clinical Oncology; 12/10/2023, Vol. 41 Issue 35, p5363-5375, 16p
Subject
Language
ISSN
0732183X